Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 37525 

Controlled substance Drug 

code Schedule 

Phenylacetone ................ 8501 II 

Poppy Straw Concentrate.9670 II 

Tapentadol ...................... 9780 II 

The company plans to import narcotic 

raw materials to manufacture bulk 

controlled substances for distribution to 

its customers. The company plans to 

import an intermediate form of 

tapentadol (9780), to bulk manufacture 

tapentadol for distribution to its 

customers. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16467 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Galephar Pharmaceutical 

Research Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 31, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 31, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

delegated to the Assistant Administrator 

of the DEA Diversion Control Division 

(‘‘Assistant Administrator’’) pursuant to 

section 7 of 28 CFR part 0, appendix to 

subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on July 3, 

2018, Galephar Pharmaceutical 

Research Inc., #100 Carr 198 Industrial 

Park, Juncos, Puerto Rico 00777 applied 

to be registered as an importer of the 

following basic class of controlled 

substance: 

Controlled substance Drug 

code Schedule 

Hydromorphone .............. 9150 II 

The company plans to import the 

listed controlled substance in finished 

dosage form for clinical trials, research 

and analytical purposes. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16466 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Ultra Scientific Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 31, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 31, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on April 

4, 2018, Ultra Scientific Inc., 250 Smith 

Street, North Kingstown, Rhode Island 

02852 applied to be registered as an 

importer of the following basic classes 

of controlled substances: 

Controlled substance Drug 

code Schedule 

Marihuana ....................... 7360 I 

Tetrahydrocannabinols ... 7370 I 

The company plans to import 

derivatives of the listed controlled 

substances for use as chemical 

standards for testing and calibration 

only of analytical equipment. The above 

controlled substances will not be 

imported for human or animal 

consumption. 

Dated: July 23, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16465 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Anderson Brecon, Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 


sradovich on DSK3GMQ082PROD with NOTICES
37526 Federal Register / Vol. 83, No. 148 / Wednesday, August 1, 2018 / Notices 

issuance of the proposed registration on 

or before August 31, 2018. Such persons 

may also file a written request for a 

hearing on the application on or before 

August 31, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on 

February 6, 2018, Anderson Brecon, 

Inc., 4545 Assembly Drive, Rockford, 

Illinois 61109 applied to be registered as 

an importer of Tetrahydrocannabinols 

(7370), a basic class of controlled 

substance listed in Schedule I. 

The company plans to import for 

clinical trial only. Approval of 

applications will occur only when 

registrant’s business activity is 

consistent with what is authorized 

under 21 U.S.C 952 (a) (2). 

Authorization will not extend to the 

import of FDA approved or nonapproved finished dosage forms for 

commercial sale. 

Dated: July 20, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16464 Filed 7–31–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Office of Justice Programs 

[OMB Number XXXX-New] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; New 

Collection 

AGENCY: SMART Office, Office of Justice 

Programs, Department of Justice. 

ACTION: 30 Day Notice. 

SUMMARY: The Department of Justice, 

Office of Justice Programs, SMART 

Office, is submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: The Department of Justice 

encourages public comment and will 

accept input until August 31, 2018. 

FOR FURTHER INFORMATION CONTACT: If 

you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Samantha Opong, Program Specialist, 

SMART Office, 810 7th Street NW 

Washington, DC 20531, 

Samantha.Opong@usdoj.gov, (202) 514– 

9320. Written comments and/or 

suggestions can also be sent to the 

Office of Management and Budget, 

Office of Information and Regulatory 

Affairs, Attention Department of Justice 

Desk Officer, Washington, DC 20503 or 

sent to OIRA_submissions@

omb.eop.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the SMART Office, 

including whether the information 

will have practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

This is a ‘‘New collection,’’ the 

collection has not previously been used 

or sponsored by the SMART Office. 

The Title of the Form/Collection: 

Campus Information Sharing and 

Response Project. 

As part of a fellowship project in the 

Office of Sex Offender Sentencing, 

Monitoring, Apprehending, Registering, 

and Tracking (SMART), Office of Justice 

Programs at the U.S. Department of 

Justice, the Campus Information Sharing 

and Response project is exploring how 

institutions of higher education share, 

respond and coordinate information to 

prevent sexual assault perpetration. 

This project will collect through an 

online questionnaire information about 

current practices utilized by colleges 

and universities with regards to the 

following: 

• Policies and practices regarding 

registered sex offenders who may be 

students or employees 

• Policies and practices regarding 

individuals found responsible and 

sanctioned for campus sexual 

misconduct policy violations 

• Policies and practices used in 

reviewing criminal or disciplinary 

sexual misconduct history of 

prospective or current students. 

2. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

There is no agency form number for this 

collection. The applicable component 

within the Department of Justice is the 

SMART Office. 

Affected public who will be asked or 

required to respond, as well as a brief 

abstract: The respondents to this 

collection/affected public includes 

business or other for profit institutions 

of higher education, and not-for-profit 

institutions. The SMART Office is 

exploring how institutions of higher 

education share, respond and 

coordinate information to prevent 

sexual assault perpetration. This project 

will collect information about current 

policies and practices utilized by 

colleges and universities regarding 

registered sex offenders who may be 

students or employees; individuals 


sradovich on DSK3GMQ082PROD with NOTICES